Montis Biosciences

Belgium
Meise, Flanders, Belgium, 1860

Company profile

Montis Biosciences company profile

Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumours.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2020-01-01, Year

Headquarters

Postal code
1860
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$9.1M
Last funding
Grant / $1.2M / 2021-06-14
Last equity funding
Seed / $9.1M
Investors
7
Lead investors
1
Founders
3

Founders and investors

Founders

Luc DochezMassimiliano MazzonePeter Carmeliet

Lead investors

Agentschap Innoveren & Ondernemen

Investors

Droia VenturesKU LeuvenPfizer Venture InvestmentsPolaris PartnersVIB